Actinium Pharmaceuticals (ATNM) Assets (2010 - 2026)
Actinium Pharmaceuticals (ATNM) reported Assets of $40.16 million for Q2 2026, down 36.3% from $63.02 million a year earlier and down 11.6% from the prior quarter.
Actinium Pharmaceuticals (ATNM) Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Actinium Pharmaceuticals posted Assets of $51.78 million, down 32.7% from FY2024.
- Assets has declined for three consecutive years, with a five-year compound annual growth rate of -4.9% (FY2020 to FY2025).
- By year, Assets came in at $76.9 million in FY2024 (-5.6%), $81.45 million in FY2023 (-28.7%), $114.19 million in FY2022 (+42.1%) and $80.39 million in FY2021 (+21.1%).
- The Q2 2026 figure ranks as the lowest quarterly Assets since Q4 2019.
- Year over year, Assets has now declined in each of the last 13 quarters, with an average decline of 25.0% over the last eight quarters.
- The high point for year-over-year Assets in five years was Q3 2021 (growth of 67.2%); the low point was Q2 2026 (a decline of 36.3%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $45.44 million (Q1 2026), $51.78 million (Q4 2025) and $56.15 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Actinium Pharmaceuticals | 37.10 Mn | 37.10 Mn | - | 40.16 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 40.16 Mn |
| Mar 31, 2026 | 45.44 Mn |
| Dec 31, 2025 | 51.78 Mn |
| Sep 30, 2025 | 56.15 Mn |
| Jun 30, 2025 | 63.02 Mn |
| Mar 31, 2025 | 68.65 Mn |
| Dec 31, 2024 | 76.90 Mn |
| Sep 30, 2024 | 82.11 Mn |
| Jun 30, 2024 | 89.86 Mn |
| Mar 31, 2024 | 88.35 Mn |
| Dec 31, 2023 | 81.45 Mn |
| Sep 30, 2023 | 88.94 Mn |
| Jun 30, 2023 | 99.05 Mn |
| Mar 31, 2023 | 102.03 Mn |
| Dec 31, 2022 | 114.19 Mn |
| Sep 30, 2022 | 116.82 Mn |
| Jun 30, 2022 | 121.80 Mn |
| Mar 31, 2022 | 74.56 Mn |
| Dec 31, 2021 | 80.39 Mn |
| Sep 30, 2021 | 84.48 Mn |
Actinium Pharmaceuticals Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=ATNM&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "ATNM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=ATNM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();